यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - augnlækningar - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

elanco gmbh - túlatrómýsín - sýklalyf til almennrar notkunar - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. the product should only be used if pigs are expected to develop the disease within 2–3 days. sauðfé: meðferð á fyrstu stigum smitandi beinbólgu (fótspyrnu) í tengslum við veirufræðilega dichelobacter nodosus sem krefst kerfisbundinnar meðferðar.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

vmd n.v. - túlatrómýsín - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. the product should only be used if pigs are expected to develop the disease within 2–3 days. sauðfé: meðferð á fyrstu stigum smitandi beinbólgu (fótspyrnu) í tengslum við veirufræðilega dichelobacter nodosus sem krefst kerfisbundinnar meðferðar.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

dechra regulatory b.v. - túlatrómýsín - sýklalyf til almennrar notkunar - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. the product should only be used if pigs are expected to develop the disease within 2–3 days. sauðfé: meðferð á fyrstu stigum smitandi beinbólgu (fótspyrnu) í tengslum við veirufræðilega dichelobacter nodosus sem krefst kerfisbundinnar meðferðar.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - Ónæmisfræðilegar upplýsingar fyrir hófdýr - hestar - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - Önnur lyf í taugakerfinu - einkenni meðferðar á lambert-eaton vöðvaspennaheilkenni (lems) hjá fullorðnum.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Æxlishemjandi lyf - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

phoenix labs - famciclovirum inn - filmuhúðuð tafla - 125 mg

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - ivermectinum inn - tafla - 3 mg

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s* - hydroxocobalaminum hýdróklóríð - stungulyf, lausn - 1 mg/ml